InspireMD to Report First Quarter 2020 Financial Results and Provide Business Update on Tuesday, May 12
InspireMD to Report First Quarter 2020 Financial Results and Provide Business Update on Tuesday, May 12
Tel Aviv, Israel— May 5, 2020 – InspireMD, Inc. (NYSE American: NSPR), developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused by carotid artery disease, announced today that management will host a conference call and webcast on Tuesday, May 12, 2020, to discuss financial results for the first quarter ended March 31, 2020, and provide a corporate update.
Conference Call & Webcast:
Tuesday, May 12th @ 8:30am EDT
Within the US: 877-451-6152
Outside the US: 201-389-0879
Conference ID: 13703268
Webcast: http://public.viavid.com/index.php?id=139696
About InspireMD, Inc.
InspireMD seeks to utilize its proprietary MicroNet™® technology to make its products the industry standard for treatment of carotid artery disease by providing outstanding acute results and durable stroke free long-term outcomes.
InspireMD’s common stock is quoted on the NYSE American under the ticker symbol NSPR and certain warrants are quoted on the NYSE American under the ticker symbols NSPR.WS and NSPR.WSB.
Investor Contacts:
Craig Shore
Chief Financial Officer
InspireMD, Inc.
888-776-6804
Jeremy Feffer
LifeSci Advisors, LLC
212-915-2568